Guardant Health, Inc. NMS · GH

Ovarian Cancer Diagnostics Market Size to Reach USD 8.08 Billion by 2035 | SNS Insider

GlobeNewswire Inc. · 32d ago

Why Grail Could Be the Sleeper Stock Everyone's About to Notice

The Motley Fool · 43d ago

AI-Powered Imaging Systems and Deep Learning Software Revolutionize Cancer Diagnostics Market Globally

GlobeNewswire Inc. · 46d ago

Guardant Health Secures FDA Approval For Expanded Liquid Biopsy Test

Benzinga · 62d ago

Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight

GlobeNewswire Inc. · 69d ago

Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind Breast Cancer Therapy

Benzinga · 78d ago

Oncology Biomarkers Market Trends and Investment Opportunities Report 2026-2030: Global, Regional and Country-Level Outlook

GlobeNewswire Inc. · 113d ago

Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings

The Motley Fool · 130d ago

FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer

Benzinga · 179d ago

Global Pan-Genomic and Multi-Gene Panel Testing Market Forecast to Hit US$ 25.91 Billion by 2032 at 12.04% CAGR, Driven by Growing Demand for Comprehensive Multi-Gene Diagnostics: AnalystView Market Insights

GlobeNewswire Inc. · 186d ago

Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line

The Motley Fool · 204d ago

Pre-Dx Oncology Market Outlook 2026–2035: A Strategic Insight by Towards Healthcare

GlobeNewswire Inc. · 235d ago

Oncology Biomarker Market Accelerates Toward USD 113.5 Billion by 2034

GlobeNewswire Inc. · 242d ago

Breast Cancer Screening Tests Market to Reach USD 8.77 Billion by 2034, Shows Steady 7.04% CAGR

GlobeNewswire Inc. · 245d ago

Molecular Diagnostics Market to Grow at 13.1% CAGR Through 2030

GlobeNewswire Inc. · 271d ago

Global Liquid Biopsy Market Set to Reach USD 7.05 Billion by 2030 | MarketsandMarkets™

GlobeNewswire Inc. · 333d ago

Guardant Health (GH) Q2 Revenue Up 31%

The Motley Fool · 355d ago

Minimal Residual Disease Testing Market Trends Analysis Report 2025-2030 | North America Leads in MRD Testing Market with Advanced Reimbursement Ecosystem

GlobeNewswire Inc. · 361d ago

Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape

GlobeNewswire Inc. · 404d ago

Epigenetics Market Anticipated to Achieve 11.8% CAGR

GlobeNewswire Inc. · 413d ago

Guardant Health: A Promising Player in the Liquid Biopsy Market

The Motley Fool · 430d ago

Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform

Benzinga · 452d ago

Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide

GlobeNewswire Inc. · 469d ago

Cancer Biomarkers Research Report 2024: Global Market Projected to Soar to USD 62.14 Billion by 2034, Driven by Technological Advancements and Increasing Demand for Early Detection

GlobeNewswire Inc. · 502d ago

Liquid Biopsy Market Worth US$11.3 billion at a robust CAGR of 11.9% | MarketsandMarkets™.

GlobeNewswire Inc. · 510d ago